Concepedia

Zsuzsanna K. Zsengellér

ZK

Statistics

Publications

75

Citations

6.7K

H-Index

44

Active since

1995

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Semmelweis University

Inotek Pharmaceuticals (United States)

Center for Vascular Biology Research

Zsuzsanna K. Zsengellér is an author at Beth Israel Deaconess Medical Center specializing in life sciences, medicine, and molecular biology.

ORCID

Publications per year

1995–2024

75

Publications

75

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

Xueliang Du, Takeshi Matsumura, Diane Edelstein et al. · Journal of Clinical Investigation · 2003 · 799 citations · Full text

, , +17

PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection

Mei Tran, Zsuzsanna K. Zsengellér, Anders H. Berg et al. · Nature · 2016 · 541 citations · Full text

, , +14

PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice

Mei Tran, Denise Tam, Amit Bardia et al. · Journal of Clinical Investigation · 2011 · 502 citations

, , +17

Pharmacological Inhibition of CB1Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity

Partha Mukhopadhyay, Sándor Bátkai, Mohanraj Rajesh et al. · Journal of the American College of Cardiology · 2007 · 207 citations · Full text

, , +11

Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy

Partha Mukhopadhyay, Béla Horváth, Zsuzsanna K. Zsengellér et al. · Free Radical Biology and Medicine · 2011 · 206 citations · Full text

, , +16

1–5 of 75